NCT06026436View on ClinicalTrials.gov

Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome

NARecruitingINTERVENTIONAL
Enrollment

850

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Kidney Disease stage3
Interventions
BIOLOGICAL

Blood samples

12-24 hours after P2Y12 ADP receptor loading dose (LD)

BIOLOGICAL

Blood samples

1 month after Percutaneous Coronary Intervention (PCI)

Trial Locations (1)

13354

RECRUITING

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER